IGATE Recharges the Brand
CNW Group - Mon May 12, 3:00AM CDT
Unveils a new identity to reflect its refreshed vision, strategy and value proposition
iGATE to Host Investors and Analysts Day on May 15
CNW Group - Fri May 09, 3:32PM CDT
iGATE, the integrated technology and operations company has scheduled an Investors and Analysts Day on May 15, 2014 at Hilton Midtown, New York.
Global Pharmacovigilance Market 2013-2019 - New Opportunities in the $2 Billion Industry
M2 - Wed May 07, 3:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mzp99x/pharmacovigilance) has announced the addition of the "Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The total market for global pharmacovigilance services is estimated to be USD 2,147.3 million in 2012 and is forecast to grow at a CAGR of 12.9% from 2013 to 2019 Some of the major players profiled in this report include PRA International Inc., Covance Inc., Synowledge LLC, OptumInsight Inc., iMedGlobal, TCS, iGATE Corporation, Cognizant Technology Solutions, Quintiles and others. Today, pharmacovigilance is considered as a continuous process of evaluation in most of the pharmaceutical companies to reduce the risks associated in bringing the new drug in to the market and to improve the safe usage of medicinal products. The proper rules and guidelines for implementation of drug safety monitoring programs has been formulated by various national and international regulatory authorities such as World Health Organization (WHO) and United States Food and Drugs Administration (USFDA). The global pharmacovigilance market has been segmented based on the type of clinical trials phases, type of service providers and by type of methods used in drug safety reporting. Based on the type of service providers, the market has been segmented in to in-house and contract outsourcing services. Among these, contract outsourcing services market accounts for the largest market share in 2012 and expected to continue the same till 2019 owing to the high cost involvement, growing regulatory concerns and requirement of highly qualified professionals for drug safety reporting. Based on type of clinical trials phases, the total market for pharmacovigilance services is categorized into pre-clinical studies, phase I, II, III and IV (post-marketing surveillance services). Among afore-mentioned services, the market for phase IV services accounts for the largest market share in 2012. Scope Clinical Trial Phases - Pre-Clinical Studies - Phase I - Phase II - Phase III - Phase IV - Post-Marketing Surveillance Service Providers - In-House - Contract Outsourcing Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Pharmacovigilance Market Dynamics Chapter 4 Global Pharmacovigilance Market, by Clinical Trial Phases Chapter 5 Global Pharmacovigilance Market, By Type of Methods Chapter 6 Global Pharmacovigilance Market, by Type of Service Providers Chapter 7 Global Pharmacovigilance Market, by Geography Chapter 8 Global Pharmacovigilance Market Share Analysis Chapter 9 Recommendations Chapter 10 Company Profiles - Accenture, Plc - Bristol-Myers Squibb - Clinquest Group B.V. - Cognizant Technology Solutions - Covance, Inc. - F. Hoffmann-La Roche Ltd. - GlaxoSmithKline (GSK) - iGATE Corporation - iMEDGlobal Corporation - inVentiv Health Inc. - ICON, Plc - Infosys - Johnson and Johnson - Novartis International AG - OptumInsight, Inc. - PRA International, Inc. - Parexel International Corporation - Pfizer, Inc. - Pharmaceutical Product Development, Inc. (PPD, Inc.) - Quantum Solutions India - Quintiles Transnational Corporation - Sanofi Aventis - Synowledge LLC - United BioSource Corporation - Wipro Limited For more information visit http://www.researchandmarkets.com/research/mz...ovigilance
Demandware (DWRE) Catches Eye: Stock Moves 11.2% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 8:46AM CDT
Demandware (DWRE) was a big mover last session, with shares rising over 11% on the day.
Digital River (DRIV) Jumps: Stock Adds 6.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 8:25AM CDT
Digital River (DRIV) was a big mover last session, with shares rising nearly 7% on the day.
CACI Q3 Earnings Way Ahead of Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 3:30PM CDT
CACI International Inc. (CACI) reported relatively modest third quarter fiscal 2014 results with a focused market-driven strategy and strong cash flow.
Uptrend Call Working As iGate Stock Rises 11.7% (IGTE)
Comtex SmarTrend(R) - Thu May 01, 11:20AM CDT
SmarTrend identified an Uptrend for iGate (NASDAQ:IGTE) on April 2nd, 2014 at $32.55. In approximately 4 weeks, iGate has returned 11.71% as of today's recent price of $36.36.
Innodata (INOD) Catches Eye: Stock Surges 13.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 8:25AM CDT
Innodata was a big mover last session, with shares rising nearly 14% on the day.
iGATE Receives 2014 Global Customer Value Leadership Award
PR Newswire Europe - Tue Apr 29, 7:04AM CDT
BRIDGEWATER, New Jersey, April 29, 2014 /PRNewswire/ --
iGate Earnings Review: 18 Days after Announcement Shares Down 7.5% (IGTE)
Comtex SmarTrend(R) - Mon Apr 28, 6:59AM CDT
When iGate (NASDAQ:IGTE) reported earnings 18 days ago on April 10th, 2014, analysts, on average, expected the company to report earnings of $0.42 on sales of $300.9 million. The company actually reported EPS of $0.45 on sales of $302.2 million, beating EPS estimates by $0.03 and beating revenue estimates by $1.3 million. Since the company's report, shares of iGate have fallen from $38.65 to $35.74, representing a loss of 7.5% in the past 18 days.
Logitech's Q4 Earnings Surpass Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 12:33PM CDT
Logitech International SA (LOGI) reported fiscal fourth-quarter 2014 earnings of 14 cents per share versus the Zacks Consensus Estimate of a loss of 1 cent.
iGate Up 13.9% Since SmarTrend Uptrend Call (IGTE)
Comtex SmarTrend(R) - Thu Apr 24, 10:01AM CDT
SmarTrend identified an Uptrend for iGate (NASDAQ:IGTE) on April 2nd, 2014 at $32.55. In approximately 3 weeks, iGate has returned 13.92% as of today's recent price of $37.08.
iGATE Ranked Amongst the Global 'High Performers' in the HfS Enterprise Mobility Services Blueprint Report 2014
CNW Group - Tue Apr 22, 7:48AM CDT
Endorses iGATE as a forward-thinking company building solutions catering to future market needs
iGate Has Returned 15.2% Since SmarTrend Recommendation (IGTE)
Comtex SmarTrend(R) - Thu Apr 17, 9:23AM CDT
SmarTrend identified an Uptrend for iGate (NASDAQ:IGTE) on April 2nd, 2014 at $32.55. In approximately 2 weeks, iGate has returned 15.21% as of today's recent price of $37.50.
Earnings Estimates Moving Higher for iGATE (IGTE): Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 7:31AM CDT
iGATE, the provider of Computer Services, could be a solid choice for investors, as it has witnessed solid activity on the earnings estimate revision front and the company also has a favorable Zacks Rank.